Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis

Genomic studies have revealed significant branching heterogeneity in cancer. Studies of resistance to tyrosine kinase inhibitor therapy have not fully reflected this heterogeneity because resistance in individual patients has been ascribed to largely mutually exclusive on-target or off-target mechan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Smith, Catherine C., Paguirigan, Amy, Jeschke, Grace R., Lin, Kimberly C., Massi, Evan, Tarver, Theodore, Chin, Chen-Shan, Asthana, Saurabh, Olshen, Adam, Travers, Kevin J., Wang, Susana, Levis, Mark J., Perl, Alexander E., Radich, Jerald P., Shah, Neil P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5501146/
https://ncbi.nlm.nih.gov/pubmed/28490572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-04-711820
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados